Top Markets
#1 Gama Token Gama Token +8.43%
#2 Akedo Akedo +6.00%
#3 Palladium Network Palladium Network +5.79%
#4 Cross Cross +4.45%
#5 Audiera Audiera +4.11%
#6 Ribbita by Virtuals Ribbita by Virtuals +3.29%
#7 Humanity Humanity +3.25%
#8 Perle Perle +3.24%
#9 BNB Attestation Service BNB Attestation Service +2.64%
#10 OKZOO OKZOO +2.56%
Coin of the day
Gama Token Gama Token
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
Fresh Tracks Therapeutics, Inc. Fresh Tracks Therapeutics, Inc.

Fresh Tracks Therapeutics, Inc.

FRTX
शेयरों में रैंक #36397
Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused... Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused on creating diverse prescription therapies to address a range of severe autoimmune, inflammatory, and other chronic debilitating conditions, primarily within the U.S. market. A key compound in its development pipeline is sofpironium bromide, which has successfully completed Phase III clinical trials for the management of primary axillary hyperhidrosis. The company is also advancing BBI-02, an oral DYRK1A inhibitor targeting autoimmune and inflammatory diseases, and BBI-10, a covalent STING pathway inhibitor with potential for treating autoinflammatory and rare genetic disorders. Furthermore, Fresh Tracks is engaged in developing next-generation kinase inhibitors. The company maintains crucial licensing and collaborative partnerships, including agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. (and Dr. Nicholas S. Bodor), and AnGes, Inc. Founded in 2009 and based in Boulder, Colorado, the organization rebranded in September 2022, previously operating under the name Brickell Biotech, Inc.
शेयर मूल्य
$0.94
अंतिम समन्वयन: 2025-02-28
मार्केट कैप
$2.73M
बदलाव (1 दिन)
0.00%
बदलाव (1 वर्ष)
0.00%
देश
US
व्यापार Fresh Tracks Therapeutics, Inc. (FRTX)

श्रेणी

Healthcare
Fresh Tracks Therapeutics, Inc. (FRTX) के लिए राजस्व
Dec 2023 में राजस्व TTM: $8.01M
Fresh Tracks Therapeutics, Inc. की नवीनतम वित्तीय रिपोर्टों के अनुसार, कंपनी की वर्तमान राजस्व (TTM) $8.01M है। 2022 में, कंपनी ने $6.94M का राजस्व अर्जित किया जो 2021 के $404.00K के राजस्व से की वृद्धि है। राजस्व वह कुल आय है जो कंपनी अपने उत्पादों या सेवाओं की बिक्री से उत्पन्न करती है। लाभ की तुलना में इसमें कोई खर्च घटाया नहीं जाता।
Fresh Tracks Therapeutics, Inc. के लिए 2000 से 2026 तक की राजस्व इतिहास
प्रत्येक वर्ष के अंत में राजस्व
वर्ष राजस्व परिवर्तन
2026 (TTM) $8.01M 0.00%
2023 $8.01M 15.31%
2022 $6.94M 1,618.56%
2021 $404.00K -77.83%
2020 $1.82M -76.99%
2019 $7.92M 388.10%
2018 $1.62M -88.26%
2017 $13.82M -4.90%
2016 $14.53M -30.64%
2015 $20.95M 37.67%
2014 $15.22M 97.16%
2013 $7.72M -55.94%
2012 $17.52M -41.64%
2011 $30.02M 244.60%
2010 $8.71M -31.33%
2009 $12.69M 59.45%
2008 $7.96M 44.34%
2007 $5.51M -62.61%
2006 $14.74M 22.80%
2005 $12.00M -17.48%
2004 $14.55M 80.05%
2003 $8.08M 15.29%
2002 $7.01M -38.35%
2001 $11.37M 49.16%
2000 $7.62M 0.00%
समान कंपनियों या प्रतिस्पर्धियों के लिए राजस्व
कंपनी राजस्व राजस्व में अंतर देश
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 157,585.49%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 75,109.68%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B 126,190.12%
BE